Mutual funds are subject to market risk. Read all scheme documents carefully.
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
Our score weighs long-term performance, risk and consistency — not just past returns.
As of 5 Nov 2026
Long Term Wealth Creation. An open ended equity scheme investing in equity and equity related instruments based on the Quality Factor.
The scheme seeks to generate long-term capital appreciation by investing in Equity & Equity related instruments of companies identified based on the Quality Factor.
Exit load of 1% if redeemed within 1 month.
As of 30 Sep 2026
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| ICICI Bank Ltd. | 6.50% | ₹130.25 Cr | 9,85,500 |
| Bharat Electronics Ltd. | 4.18% | ₹83.64 Cr | 21,54,104 |
| Divi's Laboratories Ltd. | 4.06% | ₹81.33 Cr | 87,529 |
| HDFC Bank Ltd. | 3.90% | ₹78.2 Cr | 11,03,438 |
| Others | 3.58% | ₹71.69 Cr | — |
| Mahindra & Mahindra Ltd. | 3.40% | ₹67.99 Cr | 2,30,459 |
| Sun Pharmaceutical Industries Ltd. | 2.87% | ₹57.52 Cr | 3,16,609 |
| Hindustan Unilever Ltd. | 2.65% | ₹53.13 Cr | 2,82,734 |
| Astrazeneca Pharma India Ltd. | 2.50% | ₹50.11 Cr | 81,005 |
| TD Power Systems Ltd. | 2.12% | ₹42.37 Cr | 5,38,966 |
